Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C15H22N2O.BrH |
| Molecular Weight | 327.26 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Br.[H][C@]12CCCN3CCC[C@]([H])([C@@]4([H])CC=CC(=O)N4C1)[C@]23[H]
InChI
InChIKey=NBBQEIQEBNYSFK-PUILLJIJSA-N
InChI=1S/C15H22N2O.BrH/c18-14-7-1-6-13-12-5-3-9-16-8-2-4-11(15(12)16)10-17(13)14;/h1,7,11-13,15H,2-6,8-10H2;1H/t11-,12+,13+,15-;/m0./s1
DescriptionSources: doi: 10.1248/cpb.13.482Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/24587659 | https://www.ncbi.nlm.nih.gov/pubmed/23395669 | https://www.ncbi.nlm.nih.gov/pubmed/18379053
Sources: doi: 10.1248/cpb.13.482
Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/24587659 | https://www.ncbi.nlm.nih.gov/pubmed/23395669 | https://www.ncbi.nlm.nih.gov/pubmed/18379053
Sophocarpine is a dehydrogenation derivative of the bis-quinolizidine alkaloid matrine. Sophocarpine is also an active component in sophora alkaloids, which possess a variety of pharmacological effects such as anti-inflammation, immunity regulation, antivirus, and anti-tumor actions. Sophocarpine is able to block HERG K+ channel. It is Na+ channel inward current inhibitor. It activates the AMPK signaling pathway and inhibits the TLR4-downstream pathway.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL240 |
100.0 µM [IC50] | ||
Target ID: map04152 |
|||
Target ID: Sodium channel |
|||
Target ID: TLR4 signaling pathway |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT/GSK-3β/β-catenin axis and TGF-β induced EMT with sophocarpine. | 2016-06-28 |
|
| RETRACTED: Sophocarpine displays anti-inflammatory effect via inhibiting TLR4 and TLR4 downstream pathways on LPS-induced mastitis in the mammary gland of mice. | 2016-06 |
|
| Inhibition of Sophocarpine on Poly I: C/D-GalN-Induced Immunological Liver Injury in Mice. | 2016 |
|
| [Mechanism of sophocarpine in treating experimental colitis in mice]. | 2015-08 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID00999263
Created by
admin on Wed Apr 02 21:14:02 GMT 2025 , Edited by admin on Wed Apr 02 21:14:02 GMT 2025
|
PRIMARY | |||
|
78003-71-1
Created by
admin on Wed Apr 02 21:14:02 GMT 2025 , Edited by admin on Wed Apr 02 21:14:02 GMT 2025
|
PRIMARY | |||
|
DM879U79EB
Created by
admin on Wed Apr 02 21:14:02 GMT 2025 , Edited by admin on Wed Apr 02 21:14:02 GMT 2025
|
PRIMARY | |||
|
3060327
Created by
admin on Wed Apr 02 21:14:02 GMT 2025 , Edited by admin on Wed Apr 02 21:14:02 GMT 2025
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
